Haloperidol versus olanzapine for people with schizophrenia

Khasan Ibragimov, Gregory Keane, Cristina Carreño Glaría, Jie Cheng, Augusto Llosa

Open source

DOI
10.1002/14651858.cd013425
Published
2019-10-30
Container
Cochrane database of systematic reviews (Online)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd013425,
  title = {Haloperidol versus olanzapine for people with schizophrenia},
  author = {Khasan Ibragimov and Gregory Keane and Cristina Carreño Glaría and Jie Cheng and Augusto Llosa},
  year = {2019},
  journal = {Cochrane database of systematic reviews (Online)},
  doi = {10.1002/14651858.cd013425},
  url = {https://doi.org/10.1002/14651858.cd013425}
}

RIS

TY  - JOUR
TI  - Haloperidol versus olanzapine for people with schizophrenia
AU  - Khasan Ibragimov
AU  - Gregory Keane
AU  - Cristina Carreño Glaría
AU  - Jie Cheng
AU  - Augusto Llosa
PY  - 2019
JO  - Cochrane database of systematic reviews (Online)
DO  - 10.1002/14651858.cd013425
UR  - https://doi.org/10.1002/14651858.cd013425
ER  - 

APA

Ibragimov, K., Keane, G., Glaría, C. C., Cheng, J., & Llosa, A. (2019). Haloperidol versus olanzapine for people with schizophrenia. Cochrane database of systematic reviews (Online). https://doi.org/10.1002/14651858.cd013425

Source records